Search

Teresa D. Wessendorf

Examiner (ID: 4318)

Most Active Art Unit
1639
Art Unit(s)
1627, 1648, 1816, 1639, 1806, 1503, 1636, 1803, 1809, 1818, 1811, 1618
Total Applications
1202
Issued Applications
415
Pending Applications
102
Abandoned Applications
685

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 4067886 [patent_doc_number] => 05965136 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-10-12 [patent_title] => 'Bone resorption assay' [patent_app_type] => 1 [patent_app_number] => 8/993976 [patent_app_country] => US [patent_app_date] => 1997-12-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 2 [patent_no_of_words] => 6942 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 74 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/965/05965136.pdf [firstpage_image] =>[orig_patent_app_number] => 993976 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/993976
Bone resorption assay Dec 17, 1997 Issued
Array ( [id] => 4251762 [patent_doc_number] => 06207641 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-03-27 [patent_title] => 'Pharmaceutical composition containing IFN-.gamma. inducing polypeptide or factor for treating and/or preventing IFN-.gamma. susceptive diseases' [patent_app_type] => 1 [patent_app_number] => 8/974469 [patent_app_country] => US [patent_app_date] => 1997-11-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 7106 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 244 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/207/06207641.pdf [firstpage_image] =>[orig_patent_app_number] => 974469 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/974469
Pharmaceutical composition containing IFN-.gamma. inducing polypeptide or factor for treating and/or preventing IFN-.gamma. susceptive diseases Nov 19, 1997 Issued
Array ( [id] => 4088563 [patent_doc_number] => 06025485 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-02-15 [patent_title] => 'Methods and compositions for peptide libraries displayed on light-emitting scaffolds' [patent_app_type] => 1 [patent_app_number] => 8/965477 [patent_app_country] => US [patent_app_date] => 1997-11-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 12556 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 103 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/025/06025485.pdf [firstpage_image] =>[orig_patent_app_number] => 965477 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/965477
Methods and compositions for peptide libraries displayed on light-emitting scaffolds Nov 5, 1997 Issued
08/964799 USE OF CERTAIN AMIDES AS PROBES FOR DETECTION OF ANTITUBULIN ACTIVITY AND RESISTANCE MONITORING Nov 4, 1997 Abandoned
08/963368 METHODS FOR SCREENING FOR TRANSDOMINANT INTRACELLULAR EFFECTOR PEPTIDES AND RNA MOLECULES Nov 2, 1997 Abandoned
Array ( [id] => 6973562 [patent_doc_number] => 20010003647 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-06-14 [patent_title] => 'COREATANT-INCLUDING ELECTROCHEMILUMINESCENT COMPOUNDS, METHODS, SYSTEMS AND KITS UTILIZING SAME' [patent_app_type] => new-utility [patent_app_number] => 08/936971 [patent_app_country] => US [patent_app_date] => 1997-09-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 7409 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0003/20010003647.pdf [firstpage_image] =>[orig_patent_app_number] => 08936971 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/936971
COREATANT-INCLUDING ELECTROCHEMILUMINESCENT COMPOUNDS, METHODS, SYSTEMS AND KITS UTILIZING SAME Sep 24, 1997 Abandoned
Array ( [id] => 4223252 [patent_doc_number] => 06011010 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-01-04 [patent_title] => 'Cytotoxic and antiviral compound' [patent_app_type] => 1 [patent_app_number] => 8/935073 [patent_app_country] => US [patent_app_date] => 1997-09-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2708 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/011/06011010.pdf [firstpage_image] =>[orig_patent_app_number] => 935073 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/935073
Cytotoxic and antiviral compound Sep 24, 1997 Issued
Array ( [id] => 3767620 [patent_doc_number] => 05849540 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-12-15 [patent_title] => 'Thiodepsipeptide isolated from a marine actinomycete' [patent_app_type] => 1 [patent_app_number] => 8/936460 [patent_app_country] => US [patent_app_date] => 1997-09-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 4164 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/849/05849540.pdf [firstpage_image] =>[orig_patent_app_number] => 936460 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/936460
Thiodepsipeptide isolated from a marine actinomycete Sep 23, 1997 Issued
Array ( [id] => 4349586 [patent_doc_number] => 06214793 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-04-10 [patent_title] => 'Method of treating tumors with thiodepsipeptide isolated from a marine actinomycete' [patent_app_type] => 1 [patent_app_number] => 8/936678 [patent_app_country] => US [patent_app_date] => 1997-09-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 6 [patent_no_of_words] => 4155 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/214/06214793.pdf [firstpage_image] =>[orig_patent_app_number] => 936678 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/936678
Method of treating tumors with thiodepsipeptide isolated from a marine actinomycete Sep 23, 1997 Issued
08/920874 CAP-BINDING DOMAIN OF HUMAN EUKARYOTIC PROTEIN SYNTHESIS INITIATION FACTOR EIF-4E AND THE USE THEREOF Aug 28, 1997 Abandoned
08/776133 USE OF INHIBITORS OF HUMAN S-CD23 Aug 10, 1997 Abandoned
Array ( [id] => 4103740 [patent_doc_number] => 06056958 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-05-02 [patent_title] => 'Method of treatment of arterial and venous thromboembolic disorders' [patent_app_type] => 1 [patent_app_number] => 8/901344 [patent_app_country] => US [patent_app_date] => 1997-07-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19515 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 93 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/056/06056958.pdf [firstpage_image] =>[orig_patent_app_number] => 901344 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/901344
Method of treatment of arterial and venous thromboembolic disorders Jul 27, 1997 Issued
Array ( [id] => 4102687 [patent_doc_number] => 06066721 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-05-23 [patent_title] => 'Method to produce novel polyketides' [patent_app_type] => 1 [patent_app_number] => 8/896323 [patent_app_country] => US [patent_app_date] => 1997-07-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 2283 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 135 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/066/06066721.pdf [firstpage_image] =>[orig_patent_app_number] => 896323 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/896323
Method to produce novel polyketides Jul 16, 1997 Issued
Array ( [id] => 3941708 [patent_doc_number] => 05976812 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-11-02 [patent_title] => 'Activated amphetamines' [patent_app_type] => 1 [patent_app_number] => 8/896330 [patent_app_country] => US [patent_app_date] => 1997-07-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 8353 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 113 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/976/05976812.pdf [firstpage_image] =>[orig_patent_app_number] => 896330 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/896330
Activated amphetamines Jul 16, 1997 Issued
08/883656 NEUROPROTECTIVE METHODS AND REAGENTS Jun 26, 1997 Abandoned
Array ( [id] => 941194 [patent_doc_number] => 06969584 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-11-29 [patent_title] => 'Combinatorial enzymatic complexes' [patent_app_type] => utility [patent_app_number] => 08/873601 [patent_app_country] => US [patent_app_date] => 1997-06-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 11 [patent_no_of_words] => 20411 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 143 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/969/06969584.pdf [firstpage_image] =>[orig_patent_app_number] => 08873601 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/873601
Combinatorial enzymatic complexes Jun 11, 1997 Issued
Array ( [id] => 4047634 [patent_doc_number] => 05869449 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-02-09 [patent_title] => '38-decarboxy-38-hydroxymethyl derivatives of teiocoplanin antibiotics and a process for preparing them' [patent_app_type] => 1 [patent_app_number] => 8/872461 [patent_app_country] => US [patent_app_date] => 1997-06-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7129 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 99 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/869/05869449.pdf [firstpage_image] =>[orig_patent_app_number] => 872461 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/872461
38-decarboxy-38-hydroxymethyl derivatives of teiocoplanin antibiotics and a process for preparing them Jun 9, 1997 Issued
Array ( [id] => 4186389 [patent_doc_number] => 06042824 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-03-28 [patent_title] => 'Methods using cross linked protein crystal formulations as catalysts in organic solvents' [patent_app_type] => 1 [patent_app_number] => 8/868088 [patent_app_country] => US [patent_app_date] => 1997-06-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11995 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/042/06042824.pdf [firstpage_image] =>[orig_patent_app_number] => 868088 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/868088
Methods using cross linked protein crystal formulations as catalysts in organic solvents Jun 2, 1997 Issued
Array ( [id] => 4046980 [patent_doc_number] => 05912344 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-06-15 [patent_title] => 'Chemiluminescent group-containing carbodiimide compound' [patent_app_type] => 1 [patent_app_number] => 8/858127 [patent_app_country] => US [patent_app_date] => 1997-05-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4135 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/912/05912344.pdf [firstpage_image] =>[orig_patent_app_number] => 858127 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/858127
Chemiluminescent group-containing carbodiimide compound May 18, 1997 Issued
Array ( [id] => 4404663 [patent_doc_number] => 06309646 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-10-30 [patent_title] => 'Protein-polysaccharide conjugate vaccines and other immunological reagents prepared using homobifunctional and heterobifunctional vinylsulfones, and processes for preparing the conjugates' [patent_app_type] => 1 [patent_app_number] => 8/852733 [patent_app_country] => US [patent_app_date] => 1997-05-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 30 [patent_no_of_words] => 16744 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 130 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/309/06309646.pdf [firstpage_image] =>[orig_patent_app_number] => 852733 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/852733
Protein-polysaccharide conjugate vaccines and other immunological reagents prepared using homobifunctional and heterobifunctional vinylsulfones, and processes for preparing the conjugates May 6, 1997 Issued
Menu